Circulation: A Nutrition and Natural-Health Reference
1. Definition and Overview
In the broadest physiological sense, circulation refers to the continuous movement of blood through the body's closed network of blood vessels, driven by the pumping action of the heart. Humans have a closed cardiovascular system, meaning that blood never leaves the network of arteries, veins, and capillaries. Blood is circulated through blood vessels by the pumping action of the heart, pumped from the left ventricle through arteries to peripheral tissues and returning to the right atrium through veins; it then enters the right ventricle and is pumped through the pulmonary artery to the lungs and returns to the left atrium through the pulmonary veins.
In nutrition and natural-health contexts, the term "circulation" is most commonly used as shorthand for peripheral circulation — the adequacy of blood flow to the limbs, skin, and distal tissues — and the broader concept of circulatory health, which encompasses vascular tone, endothelial integrity, blood viscosity, and blood pressure regulation. Peripheral circulation refers to the blood flow in the peripheral regions of the body, such as the forearms, which is influenced by factors like blood pressure and can be measured through techniques such as venous occlusion; it is characterised by variations in blood flow rates, which can change under different physiological conditions such as exercise or hypotension.
Peripheral haemodynamics refers to blood flow, which determines oxygen and nutrient delivery to the tissues. Peripheral blood flow is affected by vascular resistance and blood pressure, which in turn varies with cardiac function.
The primary pathological expression of impaired peripheral circulation is peripheral arterial disease (PAD), also referred to as peripheral vascular disease (PVD). Patients with PAD have decreased lower extremity arterial perfusion, which is commonly referred to as "poor circulation." In most cases of PAD, atherosclerotic plaques narrow the arterial flow lumen, which restricts blood flow to the distal extremity.
PAD is a common manifestation of systemic atherosclerosis that affects over 200 million people worldwide, particularly older adults and those with diabetes, smoking history, or chronic kidney disease. This condition results from progressive arterial narrowing, most often in the aortoiliac, femoropopliteal, and infrapopliteal segments, leading to reduced or impaired blood flow to the lower extremities.
2. How It Presents: Signs and Symptoms
PAD presents along a spectrum, from asymptomatic disease to intermittent claudication and chronic limb-threatening ischaemia (CLTI).
About half the people diagnosed with PVD have no symptoms. For those with symptoms, the most common first symptom is painful leg cramping that occurs with exercise and is relieved by rest — a phenomenon known as intermittent claudication.
Reduced blood flow can cause thigh or calf pain with walking due to temporary ischaemia of the leg muscles during exertion. Walking pain from PAD is referred to as intermittent claudication, which means "to limp." Many patients with PAD have either no symptoms or atypical complaints that do not strictly conform to the definition of claudication.
Symptoms may also include changes in the skin and limbs. The legs or feet may feel numb when at rest. The legs may also feel cool to the touch, and the skin may look pale. Changes in the skin include decreased skin temperature, or thin, brittle, shiny skin on the legs and feet.
In more advanced disease, peripheral vascular disease is characterised by poor circulation to the extremities. Symptoms include swelling, numbness, loss of function, pain, and tissue death. In serious cases, the affected limb or extremity can become gangrenous and amputation is required.
Patients with PAD may experience a multitude of problems, such as claudication, ischaemic rest pain, ischaemic ulcerations, repeated hospitalisations, revascularisations, and limb loss. This may lead to a poor quality of life and a high rate of depression.
3. Body Systems Involved
Circulatory health involves multiple interacting biological systems:
- Cardiovascular system: Blood pressure is the pressure that blood exerts on the wall of the blood vessels. The pressure originates in the contraction of the heart, which forces blood out of the heart and into the blood vessels. If flow is impaired through increased resistance, then blood pressure must increase, so blood pressure is often used as a test for circulatory health.
- Vascular endothelium: The vascular endothelium refers to the inner lining of blood vessels. Although it is a simple, single layer of cells, the vascular endothelium is considered an active organ that responds to and secretes chemical signals. It regulates the passage of substances and cells from the blood to the tissues and is central to the regulation of vascular tone — the balance between blood vessel constriction and dilation.
- Nitric oxide signalling: All endothelial cells share common functions including the regulation of haemostasis, maintenance of vascular permeability, mediation of immune responses, and control of vascular tone; none of these is as critical as the nitric oxide (NO) signalling pathway. NO is a small, soluble gas with strong vasodilatory, anti-inflammatory, and antioxidant properties that plays a central role in the maintenance of vascular homeostasis.
- Smooth muscle: Autoregulation is how an organ or tissue maintains blood flow despite a change in perfusion pressure. When blood flow decreases to an organ, arterioles dilate to reduce resistance.
- Organ perfusion: Some of the organs most dependent on optimal circulation are those that process the blood for the benefit of the entire body — for example, the kidneys, liver, and spleen remove waste products or unneeded material from the blood, and the small intestine transfers nutrients from consumed food to the blood. Changes to the circulation (also called perfusion) of these organs can have ill effects on the entire body.
4. Contributing and Associated Factors
4.1 Atherosclerosis
PAD is commonly caused by atherosclerosis. This problem occurs when fatty material (plaque) builds up on the walls of the arteries and makes them narrower. The walls of the arteries also become stiffer and cannot widen (dilate) to allow greater blood flow when needed. As a result, the muscles of the legs cannot get enough blood and oxygen when they are working harder, such as during exercise or walking.
4.2 Endothelial Dysfunction
Before the development of manifest atherosclerotic lesions, all known risk factors primarily induce functional alterations in vascular endothelial cells — a condition termed endothelial dysfunction or endothelial activation, characterised by an altered availability of nitric oxide (NO). Under physiological conditions, NO is of unequivocal importance for the regulation of vascular homeostasis. Abnormalities in NO production by the vascular endothelium result in endothelial dysfunction, which occurs in hypertension, diabetes, ageing, and as a prelude to atherosclerosis. The common feature of endothelial dysfunction is a decrease in the amount of bioavailable NO.
Endothelial dysfunction is a hallmark of cardiometabolic disease. Central to this process is nitric oxide (NO), whose decreased synthesis, enhanced degradation, or impaired signalling shifts vascular tone toward vasoconstriction, inflammation, and thrombosis.
4.3 Modifiable Lifestyle Risk Factors
Some risk factors for atherosclerosis are permanent (age, gender, genetic heritage) and others can be modified: tobacco smoking, physical inactivity, poor nutrition, high blood pressure, type 2 diabetes, dyslipidaemia, and obesity.
Hypertension: Over time, high blood pressure can damage artery walls, allowing plaque to build up. In the United States, high blood pressure accounts for more deaths linked to atherosclerosis than any other risk factor that can be changed.
Smoking: Smokers over the age of 60 have a doubled risk of atherosclerosis and subsequent CVD compared to non-smokers. For people under the age of 60, the risk is five times higher. Smoking narrows the arteries, decreases the blood's ability to carry oxygen, and increases the risk for forming clots (thrombi and emboli).
Diabetes: High blood sugar can damage the inner layers of the arteries, causing plaque buildup. Compared with those patients who do not suffer from diabetes, patients with diabetes have hypertension twice as often. Diabetes is also one of the most crucial risk factors for determining coronary artery disease (CAD).
Obesity and dyslipidaemia: The most common risk factors include hypercholesterolaemia (LDL-cholesterol), hypertension, diabetes mellitus, cigarette smoking, age, gender, and strong family history. Additionally, a sedentary lifestyle, obesity, diets high in saturated and trans-fatty acids, and certain genetic mutations contribute to risk.
Physical inactivity: Being physically inactive can worsen other heart disease risk factors, such as high blood cholesterol and triglyceride levels, high blood pressure, diabetes and prediabetes, and overweight and obesity.
Oxidative stress: Oxidative stress is thought to be an early, causative event in the onset of endothelial dysfunction and atherosclerosis. Evidence supports a major contribution by oxidative stress-induced destruction of nitric oxide to the endothelial dysfunction that accompanies a number of cardiovascular disease states including hypertension, diabetes, chronic heart failure, and atherosclerosis.
Unhealthy diet: Unhealthy eating patterns, including consuming a lot of saturated fats and refined carbohydrates (such as white bread, pasta, and white rice), can lead to overweight and obesity, high blood cholesterol, atherosclerosis, and plaque buildup in the heart's arteries.
Inflammation: Lifestyle risk factors influence disease risk via effects on novel risk factors such as endothelial function, inflammation/oxidative stress, thrombosis/coagulation, arrhythmia, and other pathways.
5. Nutrients, Herbs, and Natural Ingredients
5.1 Dietary Nitrates and Beetroot
Traditional Use
Beetroot (Beta vulgaris) has a long history of use in European folk medicine for supporting vitality and blood health, though its specific association with vascular nitric oxide biology is a modern discovery, not a traditional application.
Scientific Evidence
Dietary inorganic nitrate in beetroot can act as a source of nitric oxide and has been reported to lower brachial blood pressure (BP).
A 2014 randomised, double-blind, placebo-controlled clinical trial (n=68 hypertensive patients) found that single-dose administration of dietary inorganic nitrate acutely reduces blood pressure in normotensive healthy volunteers via bioconversion to the vasodilator nitric oxide. Researchers randomly assigned 68 hypertensive patients to receive daily dietary supplementation for 4 weeks with either dietary nitrate (250 mL daily, as beetroot juice) or a nitrate-free beetroot juice placebo. In this trial, nitrate-replete beetroot juice reduced systolic BP by a mean of 9.0 ± 7.8 mm Hg after 4 weeks, compared to 0.1 ± 8.0 mm Hg in the nitrate-deplete group.
A 2013 meta-analysis of 16 eligible randomised crossover trials evaluated the relationship between inorganic nitrate or beetroot juice supplementation and blood pressure and verified a strong association of dietary nitrate consumption with blood pressure reduction (mean average reductions: −4.4 mmHg and −1.1 mmHg for systolic and diastolic blood pressure, respectively).
Evidence strength: Moderate to good for short-term blood pressure reduction in controlled studies, primarily in normotensive and mildly hypertensive adults. Evidence for long-term cardiovascular outcomes and peripheral perfusion improvement specifically is more limited and preliminary.
5.2 L-Arginine and L-Citrulline
Traditional Use
L-Arginine and L-Citrulline are amino acids found in foods such as watermelon, nuts, and meat. They have no documented traditional medicinal history; their cardiovascular relevance was identified through 20th-century biochemical research.
Scientific Evidence
NO is generated intracellularly from L-arginine via NO-synthase with the help of several cofactors, including tetrahydrobiopterin. L-Arginine supplementation has been studied for its potential to raise nitric oxide bioavailability and improve vascular function. The mechanisms by which L-arginine enhances NO production, improves vascular elasticity, and alleviates endothelial dysfunction caused by reduced NO bioavailability have been investigated.
Nitrate (NO₃⁻), L-arginine, L-citrulline, and potassium can mitigate arterial dysfunction and stiffness by intensifying NO bioavailability. Dietary compounds such as L-arginine, L-citrulline, NO₃⁻, and potassium exert vasoactive effects as demonstrated in clinical interventions by noninvasive flow-mediated vasodilation (FMD) and pulse-wave velocity (PWV) prognostic techniques. Specifically, daily L-arginine intakes ranging from 4.5 to 21 g lead to increased FMD and reduced PWV responses.
Isolated L-citrulline intake of at least 5.6 g has a better effect compared to watermelon extract, which is only effective on endothelial function when supplemented for longer than 6 weeks and contains at least 6 g of L-citrulline.
Evidence strength: Preliminary to moderate. Most trials are small and short-term. L-Arginine supplementation at high doses shows measurable effects on surrogate vascular markers (FMD, PWV), but translation to hard cardiovascular outcomes remains unestablished. L-Citrulline evidence is at an earlier stage.
5.3 Omega-3 Fatty Acids (EPA and DHA)
Traditional Use
Coastal and Arctic populations — including Greenlandic Inuit — consumed high quantities of fatty fish and marine mammals rich in EPA and DHA. Early epidemiological observations in the 1970s noted the low cardiovascular disease incidence in these populations, prompting systematic scientific investigation.
Scientific Evidence
The omega-3 fatty acids found in fish and fish oils (eicosapentaenoic and docosahexaenoic acids, EPA and DHA) have been reported to have a variety of beneficial effects in cardiovascular diseases. Ecological and prospective cohort studies as well as randomised controlled trials have supported the view that the effects of these fatty acids are clinically relevant.
The cardioprotective benefits of omega-3 fatty acids may be attributed to multiple physiological effects on lipids, blood pressure, vascular function, cardiac rhythms, platelet function, and inflammatory responses.
A 2021 systematic review and meta-analysis of 38 randomised controlled trials (n=149,051 participants) found that omega-3 fatty acids were associated with reducing cardiovascular mortality (RR 0.93 [0.88–0.98]), non-fatal myocardial infarction (RR 0.87 [0.81–0.93]), coronary heart disease events (RR 0.91 [0.87–0.96]), major adverse cardiovascular events (MACE) (RR 0.95 [0.92–0.98]), and revascularisation (RR 0.91 [0.87–0.95]). Notably, the meta-analysis showed higher relative risk reductions with EPA monotherapy than with combined EPA+DHA for cardiovascular mortality and non-fatal MI. However, omega-3 fatty acids were also associated with increased incident atrial fibrillation (RR 1.26 [1.08–1.48]).
With respect to triglyceride reduction, a relevant risk factor for vascular disease, a 9–26% reduction in circulating triglycerides was demonstrated in studies where ≥4 g/day of n-3 PUFA were consumed from either marine or EPA/DHA-enriched food sources, while a 4–51% reduction was found in studies where 1–5 g/day of EPA and/or DHA was consumed through supplements.
Evidence strength: Strong for triglyceride-lowering and moderate-to-strong for reduction of major cardiovascular events, particularly with high-dose EPA. The increased atrial fibrillation risk is a clinical caution noted in the literature.
5.4 Flavonoids and Cocoa Polyphenols
Traditional Use
Flavonoid-rich plants — including green tea, cacao, red wine grapes, citrus fruits, and berries — have been used across numerous traditional medicine systems (Traditional Chinese Medicine, Ayurveda, European herbalism) for cardiovascular and circulatory complaints, typically as teas, decoctions, or dietary staples. The mechanistic basis for these uses was not characterised until the 20th century.
Scientific Evidence
Research has suggested a number of beneficial effects arising from the consumption of dietary flavonoids, found in foods such as cocoa, apples, tea, citrus fruits, and berries, on cardiovascular risk factors such as high blood pressure and endothelial dysfunction. Evidence presented includes their potential to reduce blood pressure in hypertensive individuals, as well as increasing peripheral blood perfusion and promoting cerebral blood flow (CBF) in both healthy and at-risk populations.
Intervention studies strongly suggest that cocoa exerts a beneficial impact on cardiovascular health through the reduction of blood pressure, improvement of vascular function, modulation of lipid and glucose metabolism, and reduction of platelet aggregation. These potentially beneficial effects have been shown in healthy subjects as well as in patients with risk factors or established cardiovascular disease. Several potential mechanisms are supposed to be responsible, including activation of nitric oxide synthase, increased bioavailability of NO, and antioxidant and anti-inflammatory properties.
In a systematic review on polyphenols and oxidative stress, four studies reported statistically significant improvements in markers of oxidative stress and inflammation after flavanol-rich cocoa intake. A significant reduction in oxidative stress occurred when dark chocolate was administered to smokers as opposed to milk chocolate. Furthermore, a high dose (472.5 mg) of flavonoids through cocoa powder led to reduction in all oxidative and inflammatory markers in type 2 diabetics and to a parallel improvement in endothelial function.
A double-blind, randomised, placebo-controlled crossover study in 30 healthy men found that cocoa flavanols were effective at counteracting mental-stress-induced endothelial dysfunction and improving vascular function during mental stress; specifically, cocoa flavanols prevented the decline in brachial flow-mediated dilation (FMD) experienced 30 minutes following mental stress.
The best evidence from randomised controlled trials (RCTs) is for the cardiovascular effects of polyphenol-rich interventions, especially cocoa and tea-derived flavonoids, to improve endothelial function, lower LDL cholesterol, and lower cardiovascular event risk. However, the activities of purified phytochemicals (e.g., vitamin E and β-carotene) and purified supplements remain inconclusive or even problematic in some populations.
Evidence strength: Moderate for cocoa flavanols on endothelial function markers (FMD) and blood pressure in short-term RCTs. Evidence is weaker for long-term clinical outcomes and for isolated purified flavonoid supplements compared to whole food sources.
5.5 Vitamin C
Traditional Use
Vitamin C (ascorbic acid) has been recognised since antiquity as essential for vascular integrity; scurvy — characterised by vascular fragility, bleeding, and poor wound healing — was documented in ancient Egyptian, Greek, and Roman texts and was a major hazard for sailors before citrus consumption was identified as preventive in the 18th century.
Scientific Evidence
Nutrients and dietary factors with antioxidant properties, in particular vitamin C, may protect the vascular endothelium from damage caused by oxidative stress. Additionally, vitamin C and certain flavonoids may increase the availability of nitric oxide, a compound that promotes vasodilation and assists endothelial function.
The antioxidant activities of vitamin C may protect the vascular endothelium from damage caused by oxidative stress and increase the availability of nitric oxide. A pooled analysis of randomised controlled trials found that supplementation with vitamin C improved markers of endothelial function, but the benefits were only seen in older individuals (>56 years).
Evidence strength: Adequate intake of vitamin C is well-established as necessary for normal vascular collagen synthesis and endothelial function. The supplementation evidence for improving endothelial function markers is modest and age-dependent according to pooled RCT data. Evidence for hard cardiovascular outcomes with supplemental vitamin C is not established.
5.6 Ginkgo biloba
Traditional Use
Ginkgo biloba extract is derived from the leaves of the Ginkgo biloba tree and has been used in traditional Chinese medicine for centuries. In Traditional Chinese Medicine, ginkgo leaf preparations were used for respiratory complaints and to promote blood circulation. Standardised extracts (notably EGb 761) became widely used in Europe from the mid-20th century, with Germany's Commission E approving it for peripheral arterial occlusive disease and associated symptoms.
Scientific Evidence
Ginkgo biloba is a vasoactive agent which is believed to have a positive effect on walking ability in patients with PAD.
However, a Cochrane systematic review (updated 2013), examining randomised controlled trials of Ginkgo biloba extract versus placebo in people with intermittent claudication, concluded: overall, there is no evidence that Ginkgo biloba has a clinically significant benefit for patients with peripheral arterial disease.
Eleven trials involving 477 participants compared Ginkgo biloba with placebo and assessed absolute claudication distance (maximal walking distance). At the end of the study, the absolute claudication distance increased with an overall effect size of 3.57 kcal (p = 0.06) for treatment with Ginkgo biloba compared to placebo. This translates to an increase of 64.5 metres (confidence interval −1.8 to 130.7) on a flat treadmill. This result did not reach statistical significance and was not considered clinically meaningful.
Evidence strength: Weak to none for peripheral arterial disease / intermittent claudication based on Cochrane-level systematic review evidence. The traditional use and the pharmacological vasoactive properties of Ginkgo biloba are established, but clinical trials do not translate these to meaningful improvements in walking distance or circulation in PAD patients.
5.7 Garlic (Allium sativum)
Traditional Use
Garlic has been used as both food and medicine for thousands of years across Egyptian, Greek, Roman, Chinese, and Indian traditions, prominently for cardiovascular and circulatory complaints. Hippocrates is recorded as prescribing garlic for various conditions. Ayurvedic and Traditional Chinese Medicine texts describe garlic preparations for promoting blood circulation, resolving blood stasis, and treating hypertension.
Scientific Evidence
Flavones are present in foods like garlic, chamomile tea, and celery, which are rich in luteolin. The advantageous effects of luteolin observed in various studies include blood pressure reduction in hypertensive animal models, improving vasodilation of the aortic rings, and increasing cAMP accumulation due to the inhibition of cAMP-specific phosphodiesterase. The activation of the cAMP/PKA cascade increases endothelial cell nitric oxide levels through the activation of endothelial nitric oxide synthase.
Note: While mechanistic and animal data on garlic and related compounds are substantial, the clinical evidence base for garlic's effect on peripheral circulation in human RCTs is more limited. Meta-analyses have demonstrated modest blood pressure-lowering effects of garlic preparations, and some trials suggest beneficial effects on lipid profiles, both of which are relevant risk factors for poor circulation; however, specific evidence for improved peripheral perfusion in PAD patients is not well-established from the sources reviewed.
Evidence strength: Modest clinical evidence for blood pressure and lipid effects; mechanistic evidence for vascular NO-related pathways. Direct clinical evidence for peripheral circulation improvement is preliminary.
6. Dietary and Lifestyle Factors
6.1 Mediterranean Diet
Lifestyle modifications, including smoking cessation, dietary changes, and physical activity, are currently the most cost-effective interventions for managing peripheral circulation and cardiovascular risk. Inverse associations with PAD have been reported for some subtypes of dietary fats, fibre, antioxidants (vitamins E and C), folate, vitamins B6, B12 and D, flavonoids, and fruits and vegetables. A possible inverse association between better adherence to the Mediterranean diet and the risk of symptomatic PAD has also been reported in a large randomised clinical trial.
The PREDIMED trial, a major parallel, multicenter, randomised trial conducted in Spain, examined diet–cardiovascular disease relationships in a large high-risk population. This prospective analysis included 7,122 participants from the PREDIMED study at high cardiovascular risk but free of cardiovascular disease at baseline. LS7 scores were calculated using seven metrics: smoking status, body mass index, physical activity, blood pressure, total cholesterol, glucose metabolism, and adherence to the Mediterranean diet.
Evidence has been gathered to summarise available evidence-based dietary interventions on the effectiveness of the Mediterranean diet for cardiovascular prevention and therapeutic efficacy in various types of CVD, including coronary heart disease, cerebrovascular events, heart failure, peripheral artery disease, atrial fibrillation, and sudden cardiac death.
6.2 Nitrate-Rich Vegetables
Nitrate-rich green leafy vegetables have shown promising blood pressure-lowering effects and improved endothelial function in healthy adults. Vegetables such as spinach, rocket (arugula), celery, beetroot, lettuce, and broccoli are particularly high in dietary nitrate. Single-dose administration of dietary inorganic nitrate acutely reduces blood pressure in normotensive healthy volunteers via bioconversion to the vasodilator nitric oxide.
6.3 Reduction of Saturated Fat, Trans Fat, and Refined Carbohydrates
Controlling lifestyle-related factors, including diet and exercise, is fundamental to preventing atherosclerosis. Atherogenic and hypocaloric diets lead to hypertension, diabetes, dyslipidaemia, overweight, and other disorders. Reducing intake of foods high in saturated and trans-fatty acids is specifically cited in multiple authoritative guidelines as a means of reducing LDL cholesterol and atherosclerotic plaque accumulation.
6.4 Physical Activity and Exercise
Regular physical activity (exercise training) reduces cardiovascular disease risk. Numerous studies support the hypothesis that exercise training improves vascular endothelial function, especially when it has been impaired by pre-existing conditions.
For those with existing impaired circulation, supervised exercise has specific evidence: walking or doing another activity to the point of pain, alternating with rest periods, may improve circulation over time as new, small blood vessels form.
The combination of Mediterranean diet with structured physical exercise has also been studied. A lifestyle intervention combining Mediterranean diet adherence with structured physical exercise provides robust evidence as an effective and feasible strategy to enhance cardiometabolic health in physically inactive adults. Physical activity aligned with WHO recommendations is associated with improvements in cardiovascular health, body composition, and quality of life. The WHO advises that adults aged 18–64 engage in at least 150 minutes of moderate-intensity activity or 75 minutes of vigorous-intensity activity weekly, along with muscle-strengthening activities at least twice per week.
6.5 Smoking Cessation
Poor diet, physical inactivity, and smoking are the most proximal risk factors for cardiovascular disease. Almost one-third of deaths caused by coronary heart disease are linked to smoking or exposure to secondhand smoke. Smoking cessation is consistently cited as the single most impactful modifiable intervention for peripheral vascular risk.
6.6 Alcohol
Drinking too much alcohol can raise blood pressure and the risk for heart disease. Drinking more than two drinks a day for men or one drink a day for women can raise levels of cholesterol and triglycerides. These are direct risk factors for the atherosclerotic processes that underlie impaired peripheral circulation.
6.7 Sleep
Not getting enough quality sleep, including waking up often throughout the night, may raise the risk of coronary heart disease. While sleeping, the heart does not work as hard as it does when awake. Waking up suddenly can cause a sharp increase in blood pressure and heart rate, which has been linked to angina and heart attacks.
7. Summary of Evidence Grades
- Dietary nitrates / beetroot juice: Moderate evidence for short-term blood pressure reduction via nitric oxide; limited long-term outcome data.
- Omega-3 fatty acids (EPA/DHA): Strong evidence for triglyceride reduction; moderate-to-strong evidence for reduction in major cardiovascular events (especially EPA alone); caution regarding atrial fibrillation risk at high doses.
- Cocoa flavanols / dietary polyphenols: Moderate evidence from RCTs for endothelial function and blood pressure improvement; evidence strongest for whole-food sources rather than isolated supplements.
- L-Arginine / L-Citrulline: Preliminary-to-moderate evidence from small RCTs for surrogate vascular markers (FMD, PWV); lack of large outcome trials.
- Vitamin C: Adequate intake established as essential for vascular integrity; supplementation shows modest endothelial benefit mainly in older individuals.
- Ginkgo biloba: No clinically significant benefit demonstrated in Cochrane systematic review for PAD/intermittent claudication despite traditional use and vasoactive properties.
- Mediterranean diet pattern: Consistent evidence across large trials for reduced cardiovascular risk, including peripheral artery disease association.
- Exercise (supervised walking): Well-supported by clinical evidence for improving functional capacity in existing peripheral circulation impairment.
- Smoking cessation: Among the most evidence-supported interventions for vascular risk reduction.
References
- Peripheral Arterial Disease — StatPearls, NCBI Bookshelf (NIH)
- Physiology, Cardiovascular — StatPearls, NCBI Bookshelf (NIH)
- Atherosclerosis — StatPearls, NCBI Bookshelf (NIH)
- Peripheral artery disease — legs: MedlinePlus Medical Encyclopedia (NIH)
- Peripheral Vascular Disease — Johns Hopkins Medicine
- Peripheral Artery Disease: Current Insight — PMC / NIH
- Atherosclerosis — Causes and Risk Factors, NHLBI, NIH
- Coronary Heart Disease — Risk Factors, NHLBI, NIH
- Hypertension as a Risk Factor for Atherosclerosis — PMC / NIH
- Nitric Oxide and Endothelial Dysfunction — PMC / NIH
- Endothelial Nitric Oxide Synthase and Endothelial Dysfunction — PubMed
- Nitric Oxide-Mediated Endothelial Dysfunction — PubMed
- Endothelial Dysfunction — Linus Pauling Institute, Oregon State University
- Vasoactive Nutrients for Endothelial Dysfunction and Arterial Stiffness — PMC / NIH
- Dietary Nitrate Provides Sustained Blood Pressure Lowering in Hypertensive Patients — PMC / NIH
- Effect of Beetroot Juice on Aortic and Brachial Blood Pressure Over 24h — PMC / NIH
- Nitrate-Rich Fruit and Vegetable Supplement Reduces Blood Pressure — PMC / NIH
- Effect of Omega-3 Fatty Acids on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis — PMC / NIH
- Omega-3 Fatty Acids: Their Beneficial Role in Cardiovascular Health — PubMed
- Effect of Omega-3 PUFA on Blood Triacylglycerol Levels — PMC / NIH
- Ginkgo biloba for Intermittent Claudication — Cochrane Library (2013)
- From the Cochrane Library: Ginkgo biloba for Intermittent Claudication — PubMed
- Cocoa, Blood Pressure, and Vascular Function — PMC / NIH
- Cocoa Flavanols Improve Vascular Responses to Acute Mental Stress — PMC / NIH
- Effects of Flavonoids on Cardiovascular Health: Human Intervention Trials — PMC / NIH
- Plant Polyphenols and Their Potential Benefits on Cardiovascular Health — PMC / NIH
- Dietary Phytochemicals in Cardiovascular Disease Prevention — PMC / NIH
- Lifestyle and Dietary Risk Factors for Peripheral Artery Disease — PubMed
- Association of Mediterranean Diet with Peripheral Artery Disease: the PREDIMED Randomized Trial — PubMed
- Life's Simple 7 and Risk of Peripheral Artery Disease: PREDIMED Study — PMC / NIH
- Effects of Mediterranean Diet and Structured Exercise on Cardiovascular Variables — PMC / NIH
- Vascular Nitric Oxide and Oxidative Stress — PubMed
- Beyond Established and Novel Risk Factors — AHA Journals / Circulation
- L-Arginine and Nitric Oxide in Vascular Regulation — MDPI Nutrients
Go back